| Medical and Health Sciences | Lifetime | 69 | IT 2 | 100.00 |
| Biological Sciences | Lifetime | 984 | IT 14 | 99.88 |
| Medical and Health Sciences | 2021-2025 | 955 | IT 63 | 99.77 |
| History and Archaeology | 2021-2025 | 657 | IT 63 | 87.87 |
| Nephrology | Lifetime | 2 | IT 1 | 99.98 |
| Immunology | Lifetime | 93 | IT 3 | 99.84 |
| Cardiology and Cardiovascular Medicine | Lifetime | 345 | IT 20 | 99.55 |
| Surgery | Lifetime | 663 | IT 26 | 99.38 |
| Transplantation | Lifetime | 23 | IT 1 | 99.30 |
| Medical Genetics | Lifetime | 139 | IT 14 | 98.98 |
| Pulmonary and Respiratory Medicine | Lifetime | 569 | IT 22 | 99.19 |
| Medical Physiology | Lifetime | 585 | IT 13 | 99.00 |
| Hematology | Lifetime | 237 | IT 16 | 98.65 |
| Pediatrics, Perinatology and Child Health | Lifetime | 585 | IT 8 | 98.22 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 612 | IT 33 | 98.06 |
| Clinical Pharmacology | Lifetime | 711 | IT 16 | 96.80 |
| Clinical Biochemistry | Lifetime | 459 | IT 16 | 91.41 |
| Obstetrics and Gynecology | Lifetime | 680 | IT 26 | 92.03 |
| Biochemistry | Lifetime | 691 | IT 17 | 88.32 |
| Nephrology | 2021-2025 | 46 | IT 3 | 98.63 |
| Immunology | 2021-2025 | 128 | IT 5 | 97.43 |
| History of Science, Technology and Medicine | 2021-2025 | 115 | IT 5 | 90.94 |
| Infectious Diseases | 2021-2025 | 475 | IT 29 | 89.98 |
| Medical Genetics | 2021-2025 | 307 | IT 27 | 80.89 |
| Genetics | 2021-2025 | 840 | IT 23 | 70.31 |
| Renal Diseases and Glomerulopathies | Lifetime | 1 | IT 1 | 99.99 |
| Chronic Kidney Disease and Diabetes | Lifetime | 1 | IT 1 | 99.98 |
| Complement system in diseases | Lifetime | 1 | IT 1 | 99.97 |
| Renin-Angiotensin System Studies | Lifetime | 1 | IT 1 | 99.87 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 6 | IT 1 | 99.88 |
| Renal and Vascular Pathologies | Lifetime | 5 | IT 1 | 99.89 |
| Blood Pressure and Hypertension Studies | Lifetime | 21 | IT 4 | 99.86 |
| COVID-19 Clinical Research Studies | Lifetime | 37 | IT 3 | 99.71 |
| Dialysis and Renal Disease Management | Lifetime | 13 | IT 3 | 99.87 |
| Renal and related cancers | Lifetime | 27 | IT 1 | 99.73 |
| Blood groups and transfusion | Lifetime | 33 | IT 4 | 99.40 |
| COVID-19 and healthcare impacts | Lifetime | 43 | IT 8 | 98.77 |
| Adenosine and Purinergic Signaling | Lifetime | 37 | IT 2 | 99.05 |
| Platelet Disorders and Treatments | Lifetime | 65 | IT 9 | 99.24 |
| Neurological Complications and Syndromes | Lifetime | 22 | IT 2 | 99.20 |
| Hormonal Regulation and Hypertension | Lifetime | 100 | IT 5 | 99.39 |
| Electrolyte and hormonal disorders | Lifetime | 53 | IT 2 | 99.10 |
| Nitric Oxide and Endothelin Effects | Lifetime | 116 | IT 3 | 99.37 |
| Mesenchymal stem cell research | Lifetime | 121 | IT 9 | 99.21 |
| Vasculitis and related conditions | Lifetime | 53 | IT 3 | 99.11 |
| Long-Term Effects of COVID-19 | Lifetime | 157 | IT 24 | 98.41 |
| Organ Donation and Transplantation | Lifetime | 74 | IT 1 | 99.19 |
| Tissue Engineering and Regenerative Medicine | Lifetime | 118 | IT 3 | 99.14 |
| Hemoglobinopathies and Related Disorders | Lifetime | 138 | IT 16 | 98.77 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 86 | IT 10 | 98.87 |
| Inflammatory mediators and NSAID effects | Lifetime | 126 | IT 5 | 99.00 |
| Erythropoietin and Anemia Treatment | Lifetime | 42 | IT 5 | 99.10 |
| Organ Transplantation Techniques and Outcomes | Lifetime | 243 | IT 13 | 99.14 |
| Genetic and Kidney Cyst Diseases | Lifetime | 72 | IT 2 | 98.55 |
| Muscle and Compartmental Disorders | Lifetime | 43 | IT 3 | 98.95 |
| Acute Kidney Injury Research | Lifetime | 92 | IT 5 | 98.68 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 219 | IT 12 | 98.69 |
| Diabetes Treatment and Management | Lifetime | 318 | IT 26 | 98.77 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 210 | IT 8 | 98.41 |
| Renal function and acid-base balance | Lifetime | 139 | IT 3 | 98.14 |
| Biomedical Research and Pathophysiology | Lifetime | 64 | IT 1 | 97.97 |
| Organ and Tissue Transplantation Research | Lifetime | 95 | IT 2 | 97.31 |
| Birth, Development, and Health | Lifetime | 758 | IT 9 | 98.00 |
| Iron Metabolism and Disorders | Lifetime | 412 | IT 25 | 97.47 |
| Erythrocyte Function and Pathophysiology | Lifetime | 528 | IT 27 | 97.07 |
| Cytomegalovirus and herpesvirus research | Lifetime | 731 | IT 24 | 97.22 |
| Pregnancy and preeclampsia studies | Lifetime | 785 | IT 26 | 97.59 |
| Pharmacology and Obesity Treatment | Lifetime | 244 | IT 22 | 97.21 |
| Transplantation: Methods and Outcomes | Lifetime | 574 | IT 13 | 97.29 |
| Potassium and Related Disorders | Lifetime | 140 | IT 5 | 97.28 |
| Neurological and metabolic disorders | Lifetime | 218 | IT 6 | 95.64 |
| Ion Transport and Channel Regulation | Lifetime | 459 | IT 9 | 96.09 |
| Pregnancy and Medication Impact | Lifetime | 426 | IT 14 | 95.68 |
| Xenotransplantation and immune response | Lifetime | 143 | IT 3 | 95.68 |
| Escherichia coli research studies | Lifetime | 594 | IT 6 | 95.84 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 546 | IT 39 | 94.48 |
| Systemic Sclerosis and Related Diseases | Lifetime | 873 | IT 113 | 94.68 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 614 | IT 47 | 90.48 |
| Blood transfusion and management | Lifetime | 973 | IT 22 | 89.61 |
| History of Medicine Studies | Lifetime | 971 | IT 65 | 67.15 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 8 | IT 1 | 99.72 |
| Complement system in diseases | 2021-2025 | 3 | IT 1 | 99.44 |
| COVID-19 Clinical Research Studies | 2021-2025 | 228 | IT 20 | 98.82 |
| Long-Term Effects of COVID-19 | 2021-2025 | 290 | IT 50 | 96.91 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 119 | IT 5 | 96.76 |
| Renal and related cancers | 2021-2025 | 118 | IT 15 | 96.12 |
| Vasculitis and related conditions | 2021-2025 | 276 | IT 32 | 91.24 |
| Biomedical Research and Pathophysiology | 2021-2025 | 58 | IT 8 | 87.27 |
| Platelet Disorders and Treatments | 2021-2025 | 461 | IT 40 | 87.89 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 984 | IT 35 | 86.59 |
| Genetic and Kidney Cyst Diseases | 2021-2025 | 275 | IT 14 | 82.95 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 370 | IT 37 | 86.47 |
| Renal and Vascular Pathologies | 2021-2025 | 541 | IT 76 | 81.88 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 671 | IT 94 | 81.86 |
| Blood groups and transfusion | 2021-2025 | 623 | IT 51 | 79.51 |
| Pediatric Urology and Nephrology Studies | 2021-2025 | 981 | IT 106 | 76.42 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 530 | IT 40 | 65.34 |
| Adenosine and Purinergic Signaling | 2021-2025 | 796 | IT 83 | 65.23 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 977 | IT 67 | 48.91 |
| Neurological and metabolic disorders | 2021-2025 | 735 | IT 43 | 40.08 |
| Renin-Angiotensin System Studies | 2021-2025 | 854 | IT 21 | 29.92 |